Home > Press > Sarnoff To Commercialize ExxonMobil's Nano Materials
Abstract:
Sarnoff To Identify and Pursue Applications, Markets, and Licensees Under Five-Year Agreement
Sarnoff Corporation of Princeton, New Jersey, today announced a five-year strategic agreement with ExxonMobil Research and Engineering Company (EMRE) of Fairfax, Virginia, under which commercialization opportunities for EMRE's groundbreaking portfolio of mesoporous materials will be identified in markets outside of the petrochemical industry.
The materials, which include novel high surface area silicas, are among the first nanomaterials ever created and have been commercialized by ExxonMobil for its own use. Under the agreement Sarnoff will work with EMRE to position these materials in other markets, such as electronics and optics, where their unique properties offer significant advantages over current materials.
Sarnoff is also pursuing select third party participation in developing electronic systems and devices based on these nanomaterials. Opportunities in other applications will also be considered.
According to John Riganati, vice president of technology strategy for Sarnoff, both technical and business factors played a role in determining the initial areas of development.
"Sarnoff and ExxonMobil considered eight possible startup projects and chose three for initial exploration," said Riganati. "The selection was based on both the technical advantages of the materials and their business potential in each area."
EMRE's mesoporous materials include various types of molecular structures that can be tailored to the needs of a specific application.
Sarnoff (www.sarnoff.com), formerly RCA Labs, is an international innovation services and product development company focusing on advanced technologies and applications in video, microelectronics, imagers, and related fields.
EMRE is the downstream research and engineering arm of ExxonMobil Corporation, a leading global oil, natural gas, and petrochemicals company whose subsidiaries have operations in approximately 200 countries and territories. More information regarding ExxonMobil and technologies it licenses can be found here.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Materials/Metamaterials/Magnetoresistance
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Focused ion beam technology: A single tool for a wide range of applications January 12th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||